Clinical Translation & Personalized Therapies focuses on advancing regenerative and cell-based treatments from bench to bedside, ensuring they are safe, effective, and tailored to individual patient needs. This field bridges laboratory discoveries—such as stem cell technologies, gene editing, and tissue engineering—with real-world clinical applications. Personalized therapies utilize patient-specific cells (e.g., autologous iPSCs), genetic profiles, and biomarkers to develop customized treatments for complex diseases including cancer, neurodegenerative disorders, cardiovascular conditions, and rare genetic syndromes. Clinical translation emphasizes regulatory compliance, manufacturing standards (GMP), scalability, and ethical considerations. Ongoing efforts include optimizing delivery systems, conducting rigorous clinical trials, and integrating artificial intelligence to predict patient responses. The ultimate goal is to enhance treatment efficacy, minimize side effects, and achieve long-term therapeutic success for diverse patient populations.